Open AccessUsefulness of ω-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: A double-blind, randomized, placebo-controlled study
Author(s) -
Claudio Romano,
Salvatore Cucchiara,
A. Barabino,
V. Annese,
Concetta Sferlazzas
Publication year - 2005
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v11.i45.7118
Subject(s) - gastroenterology , docosahexaenoic acid , medicine , mesalazine , crohn's disease , placebo , eicosapentaenoic acid , randomized controlled trial , arachidonic acid , fatty acid , polyunsaturated fatty acid , ulcerative colitis , biology , biochemistry , disease , pathology , alternative medicine , enzyme
To assess the value of long-chain omega-3 fatty acids (FAs) supplementation in addition to amino-salicylic-acid (5-ASA) in pediatric patients with Crohn's disease (CD).